HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient Mice.

Abstract
Serum amyloid A (SAA) promotes endothelial inflammation and dysfunction that is associated with cardiovascular disease and renal pathologies. SAA is an apoprotein for high-density lipoprotein (HDL) and its sequestration to HDL diminishes SAA bioactivity. Herein we investigated the effect of co-supplementing HDL on SAA-mediated changes to vascular and renal function in apolipoprotein E-deficient (ApoE-/-) mice in the absence of a high-fat diet. Male ApoE-/- mice received recombinant human SAA or vehicle (control) by intraperitoneal (i.p.) injection every three days for two weeks with or without freshly isolated human HDL supplemented by intravenous (i.v.) injection in the two weeks preceding SAA stimulation. Aorta and kidney were harvested 4 or 18 weeks after commencement of treatment. At 4 weeks after commencement of treatment, SAA increased aortic vascular cell adhesion molecule (VCAM)-1 expression and F2-isoprostane level and decreased cyclic guanosine monophosphate (cGMP), consistent with SAA stimulating endothelial dysfunction and promoting atherosclerosis. SAA also stimulated renal injury and inflammation that manifested as increased urinary protein, kidney injury molecule (KIM)-1, and renal tissue cytokine/chemokine levels as well as increased protein tyrosine chlorination and P38 MAPkinase activation and decreased in Bowman's space, confirming that SAA elicited a pro-inflammatory phenotype in the kidney. At 18 weeks, vascular lesions increased significantly in the cohort of ApoE-/- mice treated with SAA alone. By contrast, pretreatment of mice with HDL decreased SAA pro-inflammatory activity, inhibited SAA enhancement of aortic lesion size and renal function, and prevented changes to glomerular Bowman's space. Taken together, these data indicate that supplemented HDL reduces SAA-mediated endothelial and renal dysfunction in an atherosclerosis-prone mouse model.
AuthorsXiaoping Cai, Gulfam Ahmad, Farjaneh Hossain, Yuyang Liu, XiaoSuo Wang, Joanne Dennis, Ben Freedman, Paul K Witting
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 21 Issue 4 (Feb 15 2020) ISSN: 1422-0067 [Electronic] Switzerland
PMID32075280 (Publication Type: Journal Article)
Chemical References
  • Apolipoproteins E
  • Havcr1 protein, mouse
  • Hepatitis A Virus Cellular Receptor 1
  • Lipoproteins, HDL
  • Serum Amyloid A Protein
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Aorta (drug effects, pathology)
  • Apolipoproteins E (deficiency, genetics)
  • Atherosclerosis (chemically induced, drug therapy, genetics, pathology)
  • Disease Models, Animal
  • Gene Expression Regulation (drug effects)
  • Hepatitis A Virus Cellular Receptor 1 (genetics)
  • Humans
  • Inflammation (chemically induced, drug therapy, genetics)
  • Kidney (drug effects, pathology)
  • Lipoproteins, HDL (pharmacology)
  • Mice
  • Mice, Knockout
  • Serum Amyloid A Protein (toxicity)
  • p38 Mitogen-Activated Protein Kinases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: